Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | EYA2 | O00167 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HMGCR | P04035 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14199728 | 0.90 | TDP1 (0.35) | TDP1EYA2APPACETSHR | |
| SCHEMBL12981236 | 0.88 | TDP1 (0.33) | TDP1EYA2APPACETSHR | |
| SCHEMBL3871128 | 0.87 | FFAR3 (0.36) | TDP1EYA2APPACETSHR | |
| SCHEMBL13023088 | 0.86 | TDP1 (0.38) | TDP1EYA2APPACETSHR | |
| SCHEMBL10197374 | 0.85 | TDP1 (0.35) | TDP1EYA2APPACETSHR | |
| SCHEMBL22291050 | 0.85 | TDP1 (0.35) | TDP1EYA2APPACETSHR | |
| SCHEMBL9660711 | 0.82 | TDP1 (0.41) | TDP1EYA2APPACETSHR | |
| SCHEMBL26311798 | 0.81 | ADRA1A (0.36) | TDP1EYA2APPACETSHR | |
| SCHEMBL6981274 | 0.81 | CA12 (0.35) | TDP1EYA2APPACETSHR | |
| SCHEMBL1547956 | 0.80 | ADRA1A (0.43) | TDP1EYA2APPACETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11185599-B2 | Formation and uses of europium | WAYNE STATE UNIVERSITY (US) | 2021-11-30 | — | — | US | disclosed |
| US-9717727-B2 | Methods of treating and preventing leukemia and other cancers of the blood and bone | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2017-08-01 | — | — | US | disclosed |
| US-8883378-B2 | Colored curable composition, color filter and method of producing color filter, solid-state image sensor and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2014-11-11 | — | — | US | disclosed |
| US-8815478-B2 | Colored curable composition, resist liquid, ink for inkjet printing, color filter, method of producing color filter, solid-state image sensor, liquid crystal display, organic EL display, image display device and colorant compound | FUJIFILM CORPORATION (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8637215-B2 | Colored curable composition, color filter and method of producing color filter, solid-state image sensor and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2014-01-28 | — | — | US | disclosed |
| US-20120264039-A1 | COLORED CURABLE COMPOSITION, RESIST LIQUID, INK FOR INKJET PRINTING, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, IMAGE DISPLAY DEVICE AND COLORANT COMPOUND | FUJIFILM CORPORATION (JP) | 2012-10-18 | — | — | US | disclosed |
| US-20120070856-A1 | CROSS-LINKING AGENTS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) | 2012-03-22 | — | — | US | disclosed |
| US-20110217636-A1 | COLORED CURABLE COMPOSITION, COLOR FILTER AND METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2011-09-08 | — | — | US | disclosed |
| US-7981920-B2 | Addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2011-07-19 | — | — | US | disclosed |
| US-20100098633-A1 | SELECTIVE SEPRASE INHIBITORS | MOLECULAR INSIGHT PHARMACEUTICALS, INC. | 2010-04-22 | — | — | US | disclosed |
| US-20090082393-A1 | New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2009-03-26 | — | — | US | disclosed |
| US-20080234221-A1 | Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents | CANJI, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| US-4801722-A | FLUORESCENT LABELS | EASTMAN KODAK COMPANY (US) | 1989-01-31 | — | — | US | disclosed |
| US-4794191-A | FLUORESCENT LABELS | EASTMAN KODAK COMPANY (US) | 1988-12-27 | — | — | US | disclosed |
| EP-0068875-B1 | FLUORESCENT CHELATES AND LABELED SPECIFIC BINDING REAGENTS PREPARED THEREFROM | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-12-23 | — | — | EP | disclosed |
| US-4637988-A | BINDING, ADSORPTION LANTHANIDE CHELATE COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1987-01-20 | — | — | US | disclosed |
| EP-0068875-A2 | Fluorescent chelates and labeled specific binding reagents prepared therefrom | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1983-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264039-A1 | COLORED CURABLE COMPOSITION, RESIST LIQUID, INK FOR INKJET PRINTING, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, IMAGE DISPLAY DEVICE AND COLORANT COMPOUND | CDYL, RET, NLRP1 | TDP1 2465/4885EYA2 189/4885APP 2855/4885 |
| US-20080234221-A1 | Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents | RNASE1, TRDMT1, POLI | TDP1 534/4885EYA2 292/4885APP 2725/4885 |
| US-20100098633-A1 | SELECTIVE SEPRASE INHIBITORS | SLC6A7, DNPEP, PREP | TDP1 3266/4885EYA2 3255/4885APP 2080/4885 |
| US-20120070856-A1 | CROSS-LINKING AGENTS | ORC3, TXN, PROC | TDP1 2833/4885EYA2 2624/4885APP 2339/4885 |
| US-11185599-B2 | Formation and uses of europium | LETM1, CECR2, MCU | TDP1 3412/4885EYA2 2531/4885APP 3622/4885 |
| US-20090082393-A1 | New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them | ACE, AGTR1, AGT | TDP1 2205/4885EYA2 3751/4885APP 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.